Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9068 |
High Similarity |
NPD2801 |
Approved |
0.9024 |
High Similarity |
NPD5494 |
Approved |
0.8951 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD1934 |
Approved |
0.8841 |
High Similarity |
NPD3882 |
Suspended |
0.8706 |
High Similarity |
NPD3818 |
Discontinued |
0.8698 |
High Similarity |
NPD6166 |
Phase 2 |
0.8698 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8698 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8631 |
High Similarity |
NPD1247 |
Approved |
0.8547 |
High Similarity |
NPD5844 |
Phase 1 |
0.8537 |
High Similarity |
NPD4380 |
Phase 2 |
0.8509 |
High Similarity |
NPD1511 |
Approved |
0.8503 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8439 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8405 |
Intermediate Similarity |
NPD1512 |
Approved |
0.84 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8391 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8391 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8363 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8333 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8324 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8314 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8294 |
Intermediate Similarity |
NPD919 |
Approved |
0.8239 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8192 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8166 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8166 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8146 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8086 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8057 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8034 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD920 |
Approved |
0.8023 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7904 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7818 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7818 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7814 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7798 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7798 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7784 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7764 |
Intermediate Similarity |
NPD943 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7706 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7604 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7581 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7457 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7423 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7419 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7419 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7407 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7394 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD37 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.736 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD4966 |
Approved |
0.736 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7348 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7321 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7313 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7302 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.73 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7216 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD2296 |
Approved |
0.72 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7165 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7164 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7094 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7094 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7076 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2494 |
Approved |
0.703 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7005 |
Intermediate Similarity |
NPD2163 |
Approved |
0.6989 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6973
|
Remote Similarity |
NPD6808 |
Phase 2 |